Stopping azithromycin mass drug administration for trachoma: A systematic review

The World Health Organization (WHO) recommends continuing azithromycin mass drug administration (MDA) for trachoma until endemic regions drop below 5% prevalence of active trachoma in children aged 1–9 years. Azithromycin targets the ocular strains of Chlamydia trachomatis that cause trachoma. Regio...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmud, Hamidah, Landskroner, Emma, Amza, Abdou, Aragie, Solomon, Godwin, William W., de Hostos Barth, Anna, O’Brien, Kieran S., Lietman, Thomas M., Oldenburg, Catherine E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266061/
https://www.ncbi.nlm.nih.gov/pubmed/34237074
http://dx.doi.org/10.1371/journal.pntd.0009491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266061/
https://www.ncbi.nlm.nih.gov/pubmed/34237074
http://dx.doi.org/10.1371/journal.pntd.0009491

Ejemplares similares